CURANUM AG

EANS-Adhoc: CURANUM AG
Financial Figures 2009

-------------------------------------------------------------------------------- ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- 31.03.2010 Ad hoc announcement CURANUM AG publishes 2009 results Occupancy stable in 2009, revenue and EBITDA budgets achieved CURANUM AG, Munich, announces its results for the 2009 financial year at today's results press conference and analyst meeting in Frankfurt. The capacity utilization of care beds and managed apartments was stable in 2009, albeit at a somewhat lower average level than in 2008. Revenue rose by 1.0% from EUR 257.1 million in 2008 to EUR 259.5 million in 2009, an increase of EUR 2.4 million. We thereby exceeded our revenue budget (EUR 257.0 million to EUR 259.0 million). The increase was due to revenue from our new Scheffelhof senior residence in Bad Dürrheim, the senior citizen residence and care facility in Braunschweig, as well as additional revenues from our outpatient service in Coburg, and from care services for occupants suffering dementia. Rental expenses rose by EUR 0.9 million or 1.65% to EUR 55.5 million (previous year: EUR 54.6 million). This was mainly due to the rental indexations of the properties we rent. Staff costs increased by EUR 2.7 million or 2.1%, from EUR 127.8 million in 2008 to EUR 130.5 million in 2009. As a consequence, earnings before interest, tax, depreciation, amortization and rents (EBITDAR) amounted to EUR 83.1 million in 2009 (previous year: EUR 83.9 million), reflecting a decline of EUR 0.8 million or 0.95% year-on-year. The EBITDAR margin stood at 32.0% (previous year: 32.6%), which represents a peak outcome on a European peer group comparison. EBITDA earnings declined from EUR 29.3 million in 2008 to EUR 27.6 million in 2009, which corresponds to an EBITDA margin of 10.64% in this reporting period (previous year: 11.4%). Compared with the previous year, depreciation and amortization rose only slightly from EUR 9.5 million in 2008 to EUR 9.8 million in 2009, representing an increase of EUR 0.3 million or 3.16%. As a consequence, earnings before interest and tax (EBIT) amounted to EUR 17.8 million (previous year: EUR 19.7 million), reflecting an EBIT margin of 6.86% in 2009 (previous year: 7.66%). The tax rate increased in 2009. Consequently, income tax and deferred tax were around EUR 0.7 million higher than budgeted. At EUR 5.8 million (previous year: EUR 7.0 million) we failed to achieve our budgeted post-tax earnings of EUR 6.5 million - EUR 8.5 million. Earnings per share amounted to EUR 0.18 in the 2009 reporting period (previous year: EUR 0.22). Cash flow from operating activities rose slightly from EUR 19.8 million to EUR 19.9 million as of the end of 2009, and the cash outflow from investing activities dropped from EUR 18.7 million to EUR 5.2 million in 2009. Cash flow from financing activities was again characterized by the redemption of financial liabilities in an amount of EUR 5.6 million (previous year: EUR 4.9 million), outgoing payments for finance leasing of EUR 7.8 million (previous year: EUR 7.6 million), as well as the dividend payment at the previous year's level at EUR 3.2 million. The full results for the 2009 financial year are available on our website at www.curanum.de in the Investor Relations area. Munich, March 31, 2010 The Management Board |Key figures IFRS as of December 31, | | | |2009 | | | | | | | | | | | | | |mil. EUR |2009 |2008 1) |YOY in % | | | | | | |Sales |259.5 |257.1 |0.93 | |Staff costs |130.5 |127.8 |2.11 | |EBITDAR |83.1 |83.9 |-0.95 | |Rental costs |55.5 |54.6 |1.65 | |EBITDA |27.6 |29.3 |-5.80 | |in % of Sales |10.6% |11.4% | | |Depreciation |9.8 |9.5 |3.16 | |EBIT |17.8 |19.7 |-9.64 | |in % of Sales |6.9% |7.7% | | |Financial results |-8.9 |-9.5 |-6.32 | |EBT |8.9 |10.2 |-12.75 | |Net profit |5.8 |7.0 |-17.14 | |EPS (EUR) *) |0.18 |0.22 |-18.18 | | | | | | |Cashflow |19.9 |19.8 |0.51 | |CPS (EUR) *) |0.62 |0.61 |1.64 | | | | | | |Cash and cash equivalents |8.9 |10.0 |-11.00 | |Equity capital |66.1 |64.1 |3.12 | |in % of balance sheet total |28.0% |27.0% | | |Balance sheet total |236.4 |237.7 |-0.55 | | | | | | |Employees |6,055 |5,953 |1.71 | |Facilities |69 |68 |1.47 | |Care places |7,805 |7,708 |1.26 | |Assisted living apartements |1,681 |1,638 |2.63 | | | | | | |*) Number of unterlying outstanding | | | |shares in 2009: 32,267,835 shares | | | |*) Number of underlying outstanding | | | |shares in 2008: 32,611,091 shares | | | |1) restated in 2009 | | | end of announcement euro adhoc -------------------------------------------------------------------------------- ots Originaltext: Curanum AG Im Internet recherchierbar: http://www.presseportal.ch Further inquiry note: Marion Mühlschlegel Tel. +49 (0)89 242065-68 Email marion.muehlschlegel@curanum.de Branche: Healthcare Providers ISIN: DE0005240709 WKN: 524070 Index: SDAX, CDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free trade Stuttgart / free trade Düsseldorf / free trade München / regulated dealing

Das könnte Sie auch interessieren: